Corbus Pharmaceuticals Holdings Inc (CRBP)
38.92
+1.67
(+4.48%)
USD |
NASDAQ |
May 02, 12:03
Corbus Pharmaceuticals Holdings Cash from Investing (Quarterly): 10.39M for Dec. 31, 2023
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 10.39M |
| September 30, 2023 | 10.90M |
| June 30, 2023 | 8.808M |
| March 31, 2023 | 5.550M |
| December 31, 2022 | 11.78M |
| September 30, 2022 | -5.971M |
| June 30, 2022 | -18.70M |
| March 31, 2022 | 42.96M |
| December 31, 2021 | -3.177M |
| September 30, 2021 | 0.2841M |
| June 30, 2021 | -13.10M |
| March 31, 2021 | -57.42M |
| December 31, 2020 | 0.0521M |
| September 30, 2020 | -0.0568M |
| June 30, 2020 | -0.0162M |
| March 31, 2020 | -0.4636M |
| December 31, 2019 | -1.292M |
| September 30, 2019 | -1.194M |
| June 30, 2019 | -0.1833M |
| March 31, 2019 | -0.0736M |
| Date | Value |
|---|---|
| December 31, 2018 | -0.2498M |
| September 30, 2018 | -0.1058M |
| June 30, 2018 | -0.6752M |
| March 31, 2018 | -1.270M |
| December 31, 2017 | -0.5802M |
| September 30, 2017 | -0.0454M |
| June 30, 2017 | -0.0417M |
| March 31, 2017 | -0.0401M |
| December 31, 2016 | -0.096M |
| September 30, 2016 | -0.0699M |
| June 30, 2016 | -0.1218M |
| March 31, 2016 | -0.0653M |
| December 31, 2015 | -0.093M |
| September 30, 2015 | -0.0048M |
| June 30, 2015 | -0.0145M |
| March 31, 2015 | -0.0017M |
| December 31, 2014 | 0.00 |
| September 30, 2014 | -0.0564M |
| June 30, 2014 | -0.008M |
| March 31, 2014 | 0.00 |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-57.42M
Minimum
Mar 2021
42.96M
Maximum
Mar 2022
-0.5713M
Average
-0.0568M
Median
Sep 2020
Cash from Investing (Quarterly) Benchmarks
| Spectral AI Inc | -- |
| Panbela Therapeutics Inc | 0.00 |
| AIM ImmunoTech Inc | -0.214M |
| Protalix BioTherapeutics Inc | -0.342M |
| Armata Pharmaceuticals Inc | -2.39M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -6.009M |
| Cash from Financing (Quarterly) | -1.905M |
| Free Cash Flow | -36.10M |
| Free Cash Flow Per Share (Quarterly) | -1.358 |
| Free Cash Flow Yield | -21.44% |